Advertisement

Topics

BRIEF-Lannett seeks to withdraw approval of abbreviated NDA for methylphenidate hydrochloride extended release tablets

03:20 EDT 19 Oct 2016 | Reuters

* Lannett comments on FDA proposal regarding methylphenidate extended release tablets

Original Article: BRIEF-Lannett seeks to withdraw approval of abbreviated NDA for methylphenidate hydrochloride extended release tablets

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Lannett seeks to withdraw approval of abbreviated NDA for methylphenidate hydrochloride extended release tablets"

Quick Search
Advertisement